Narrow your search

Library

ULiège (27)

KU Leuven (26)

ULB (23)

Odisee (21)

Thomas More Kempen (21)

Thomas More Mechelen (21)

UCLL (21)

VIVES (21)

LUCA School of Arts (10)

VDIC (9)

More...

Resource type

book (33)

periodical (6)


Language

English (36)

Undetermined (2)

French (1)


Year
From To Submit

2022 (4)

2021 (1)

2020 (1)

2017 (2)

2013 (1)

More...
Listing 1 - 10 of 39 << page
of 4
>>
Sort by

Book
Approche diagnostic du patient infecté par méthode des microarrays
Authors: --- ---
Year: 2017 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Actuellement, le diagnostic d'infections sur des prélèvements en routine clinique se fait par méthodes conventionnelles (coloration de Gram, cultures) avec comme inconvénient majeur, un délai de résultat de 1 à 2 jours en moyenne. L'émergence de méthodes par spectrométrie de masse couplées à une source d'ionisation (MALDI-TOF) ou encore de méthodes par immunoassays ont permis de réduire ce temps d'analyse. Ces dernières années, les recherches se sont également intensifiées dans le domaine de la biologie moléculaire, avec les PCR notamment. Dans ce travail seront traitées les microarrays, une méthode par biologie moléculaire se basant sur l'hybridation entre une cible (acides nucléiques) et une sonde spécifique. Sur base de nombreuses études réalisées sur cette technologie, les performances de différentes microarrays (qu'elles soient commercialisées ou non) ont ainsi été comparées, en fonction de la pathologie suspectée (infections du tractus respiratoire, du système nerveux central, du tractus digestif, du sang, du système ostéo-articulaire ou du système urinaire). La rapidité d'analyse (moins de 5 heures en moyenne) est un atout majeur de cette technologie permettant ainsi une prise en charge adéquate du patient infecté. En matière de performance, les microarrays ont une sensibilité similaire aux méthodes par culture, et ont une excellente spécificité, mais le multiplexage offre l'avantage d'analyser simultanément plusieurs pathogènes sur le même échantillon en même temps. Actuellement, les limitations de ces microarrays résultent en leur absence de détection de certains germes (non-inclus dans les panels de détection) ainsi que leur coût d'analyse élevé. Cependant, certaines études ont mis en avant le potentiel économique de certains kits lors de leur implémentation en routine clinique. Il faudrait donc réaliser de plus amples études à plus large échelle pour analyser le réel impact économique d'une éventuelle implémentation de ces panels en routine clinique. Currently, the diagnosis of an infected routine sample is made by conventional methods (Gram stains, cultures) which bears one major inconvenient: a 1 to 2 days average delay for results. The emergence of methods using spectrometry coupled with a source of ionization (MALDI-TOF) or Immunoassay have now made it possible to reduce the analysis’ time. Over past few years, research has been intensified in the field of molecular biology, especially with PCR analysis. This work will cover microarrays, a molecular method using hybridation between a target (nucleic acids) and a specific primer. Based on numerous studies, these different types of microarrays (commercialized or not) were compared according to the suspected pathology (respiratory tract, central nervous system, gastrointestinal, blood, osteo-articular system, or urinary tract). The time of analysis (less than 5 hours on average) is a major advantage for this technology which allows a rapid and appropriate care of patient. In terms of performance, microarrays have a sensitivity that is comparable to methods by culture and have excellent specificity but multiplexing allows a simultaneous analysis of different pathogens on the same sample. Nowadays, microarrays remain limited by their inability to detect certain pathogens (not included in the detection panels) as well as its cost. However certain studies have shown results of economic benefits when certain kits are used in routine clinics. Further studies should be carried on a broader scale to analysis the real economic impact of a potential implementation of these panels in routine clinics.


Periodical
Microarrays.
Year: 2012 Publisher: Basel, Switzerland : MDPI AG,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Periodical
Microarrays.
Year: 2012 Publisher: Basel, Switzerland : MDPI AG,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Periodical
Microarrays.
Year: 2012 Publisher: Basel, Switzerland : MDPI AG,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Microarray analysis of the physical genome : methods and protocols
ISBN: 9781603271912 Year: 2009 Publisher: New York (N.Y.) : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Periodical
High-throughput.
Author:
ISSN: 25715135 Year: 2017 Publisher: Basel, Switzerland : MDPI,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Microbial imaging
Authors: ---
ISBN: 0125215347 Year: 2005 Publisher: Amsterdam : Elsevier Academic Press,

Microarray Technology and Cancer Gene Profiling
Author:
ISBN: 1441922989 0387399771 9786611336707 128133670X 038739978X Year: 2007 Publisher: New York, NY : Springer New York : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Cancer is a heterogeneous disease in most respects, including its cellularity, different genetic alterations and diverse clinical behaviors. Traditional molecular analyses are reductionist, assessing only one or a few genes at a time, thus working with a biologic model too specific and limited to confront a process whose clinical outcome is likely to be governed by the combined influence of many genes. The potential of functional genomics is enormous, because for each experiment, thousands of relevant observations can be made simultaneously. Accordingly, DNA array, as other high throughput technologies, might catalyze and ultimately accelerate the development of knowledge in tumor cell biology. Although in its infancy, the implementation of DNA array technology in cancer research has already provided investigators with novel data and intriguing new hypotheses on the molecular cascade leading to cancerogenesis, tumor aggressiveness and sensitivity to antineoplastic agents. Given the revolutionary implications that the use of this technology might have in the clinical management of cancer patients, principles of DNA array-based tumor gene profiling need to be clearly understood for the data to be correctly interpreted and appreciated. In the present book, written by leading experts in each field, the technical features characterizing this powerful laboratory tool are discussed, and the applications so far described in the field of oncology are reviewed.

Analyzing microarray gene expression data
Authors: --- ---
ISBN: 0471226165 9780471226161 Year: 2004 Publisher: New York, NY : John Wiley,

Listing 1 - 10 of 39 << page
of 4
>>
Sort by